epityper assay Search Results


90
agena bioscience massarray epityper platform
Massarray Epityper Platform, supplied by agena bioscience, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/massarray epityper platform/product/agena bioscience
Average 90 stars, based on 1 article reviews
massarray epityper platform - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Sequenom mass spectrometry-based sequenom epityper system
Mass Spectrometry Based Sequenom Epityper System, supplied by Sequenom, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mass spectrometry-based sequenom epityper system/product/Sequenom
Average 90 stars, based on 1 article reviews
mass spectrometry-based sequenom epityper system - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Sequenom epityper software
Epityper Software, supplied by Sequenom, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/epityper software/product/Sequenom
Average 90 stars, based on 1 article reviews
epityper software - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Sequenom massarray epityper application guide
Massarray Epityper Application Guide, supplied by Sequenom, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/massarray epityper application guide/product/Sequenom
Average 90 stars, based on 1 article reviews
massarray epityper application guide - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Sequenom massarray epityping
Massarray Epityping, supplied by Sequenom, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/massarray epityping/product/Sequenom
Average 90 stars, based on 1 article reviews
massarray epityping - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Sequenom epityper
Summary of the results of MGMT promoter methylation testing in cases with unmethylated MGMT promoter according to the reference laboratory. There is a perfect concordance) of MGMT status in all samples irrespective of tissue fixation conditions, testing laboratory, testing technician and time point of testing. Cut-offs for defining MGMT promoter methylated vs. unmethylated cases: for MSRE: 0.32%, for PSQ: 8%. PSQ-% represent the mean-methylation values from four CpG analyzed and calculated from pyrograms.
Epityper, supplied by Sequenom, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/epityper/product/Sequenom
Average 90 stars, based on 1 article reviews
epityper - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Sequenom epityper assay
Summary of the results of MGMT promoter methylation testing in cases with unmethylated MGMT promoter according to the reference laboratory. There is a perfect concordance) of MGMT status in all samples irrespective of tissue fixation conditions, testing laboratory, testing technician and time point of testing. Cut-offs for defining MGMT promoter methylated vs. unmethylated cases: for MSRE: 0.32%, for PSQ: 8%. PSQ-% represent the mean-methylation values from four CpG analyzed and calculated from pyrograms.
Epityper Assay, supplied by Sequenom, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/epityper assay/product/Sequenom
Average 90 stars, based on 1 article reviews
epityper assay - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Sequenom epityper primers
HOXA9 promoter methylation as marker for sensitivity and resistance in bladder cancer cell lines. ( A ) Expression profiling and hierarchical clustering of top sensitive and top resistant bladder cancer cell lines identifies candidate genes to explain sensitivity and resistance to chemotherapy. The LIMMA package (version 3.28.20) was used for analyzing differential expression of RNA sequencing (RNAseq) data between sensitive and resistant cell lines; ( B ) The HOXA9 promoter is methylated in resistant cell lines ( p < 0.001). Methylation quantification of the HOX9A promoter was carried out using the <t>EpiTYPER</t> assay.
Epityper Primers, supplied by Sequenom, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/epityper primers/product/Sequenom
Average 90 stars, based on 1 article reviews
epityper primers - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Sequenom the t-cleavage transcription/rnase a cocktail from epityper reagent kit
HOXA9 promoter methylation as marker for sensitivity and resistance in bladder cancer cell lines. ( A ) Expression profiling and hierarchical clustering of top sensitive and top resistant bladder cancer cell lines identifies candidate genes to explain sensitivity and resistance to chemotherapy. The LIMMA package (version 3.28.20) was used for analyzing differential expression of RNA sequencing (RNAseq) data between sensitive and resistant cell lines; ( B ) The HOXA9 promoter is methylated in resistant cell lines ( p < 0.001). Methylation quantification of the HOX9A promoter was carried out using the <t>EpiTYPER</t> assay.
The T Cleavage Transcription/Rnase A Cocktail From Epityper Reagent Kit, supplied by Sequenom, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/the t-cleavage transcription/rnase a cocktail from epityper reagent kit/product/Sequenom
Average 90 stars, based on 1 article reviews
the t-cleavage transcription/rnase a cocktail from epityper reagent kit - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Bilthoven Biologicals epitype
HOXA9 promoter methylation as marker for sensitivity and resistance in bladder cancer cell lines. ( A ) Expression profiling and hierarchical clustering of top sensitive and top resistant bladder cancer cell lines identifies candidate genes to explain sensitivity and resistance to chemotherapy. The LIMMA package (version 3.28.20) was used for analyzing differential expression of RNA sequencing (RNAseq) data between sensitive and resistant cell lines; ( B ) The HOXA9 promoter is methylated in resistant cell lines ( p < 0.001). Methylation quantification of the HOX9A promoter was carried out using the <t>EpiTYPER</t> assay.
Epitype, supplied by Bilthoven Biologicals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/epitype/product/Bilthoven Biologicals
Average 90 stars, based on 1 article reviews
epitype - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
agena bioscience epityper
HOXA9 promoter methylation as marker for sensitivity and resistance in bladder cancer cell lines. ( A ) Expression profiling and hierarchical clustering of top sensitive and top resistant bladder cancer cell lines identifies candidate genes to explain sensitivity and resistance to chemotherapy. The LIMMA package (version 3.28.20) was used for analyzing differential expression of RNA sequencing (RNAseq) data between sensitive and resistant cell lines; ( B ) The HOXA9 promoter is methylated in resistant cell lines ( p < 0.001). Methylation quantification of the HOX9A promoter was carried out using the <t>EpiTYPER</t> assay.
Epityper, supplied by agena bioscience, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/epityper/product/agena bioscience
Average 90 stars, based on 1 article reviews
epityper - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Sequenom mass spectrometry-based dna methylation profiling sequenom massarray epityper
HOXA9 promoter methylation as marker for sensitivity and resistance in bladder cancer cell lines. ( A ) Expression profiling and hierarchical clustering of top sensitive and top resistant bladder cancer cell lines identifies candidate genes to explain sensitivity and resistance to chemotherapy. The LIMMA package (version 3.28.20) was used for analyzing differential expression of RNA sequencing (RNAseq) data between sensitive and resistant cell lines; ( B ) The HOXA9 promoter is methylated in resistant cell lines ( p < 0.001). Methylation quantification of the HOX9A promoter was carried out using the <t>EpiTYPER</t> assay.
Mass Spectrometry Based Dna Methylation Profiling Sequenom Massarray Epityper, supplied by Sequenom, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mass spectrometry-based dna methylation profiling sequenom massarray epityper/product/Sequenom
Average 90 stars, based on 1 article reviews
mass spectrometry-based dna methylation profiling sequenom massarray epityper - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

Image Search Results


Summary of the results of MGMT promoter methylation testing in cases with unmethylated MGMT promoter according to the reference laboratory. There is a perfect concordance) of MGMT status in all samples irrespective of tissue fixation conditions, testing laboratory, testing technician and time point of testing. Cut-offs for defining MGMT promoter methylated vs. unmethylated cases: for MSRE: 0.32%, for PSQ: 8%. PSQ-% represent the mean-methylation values from four CpG analyzed and calculated from pyrograms.

Journal: Clinical Neuropathology

Article Title: Clinical Neuropathology practice news 1-2014: Pyrosequencing meets clinical and analytical performance criteria for routine testing of MGMT promoter methylation status in glioblastoma

doi: 10.5414/NP300730

Figure Lengend Snippet: Summary of the results of MGMT promoter methylation testing in cases with unmethylated MGMT promoter according to the reference laboratory. There is a perfect concordance) of MGMT status in all samples irrespective of tissue fixation conditions, testing laboratory, testing technician and time point of testing. Cut-offs for defining MGMT promoter methylated vs. unmethylated cases: for MSRE: 0.32%, for PSQ: 8%. PSQ-% represent the mean-methylation values from four CpG analyzed and calculated from pyrograms.

Article Snippet: Case 8 , Sequenom , 2 , RCLPE , Epityper , 1 , 31.3 , methylated.

Techniques: Methylation

Summary of the results of MGMT promoter methylation testing in cases with methylated MGMT promoter according to the reference laboratory. There is a perfect correlation (100% concordance) of MGMT status in all samples irrespective of tissue fixation conditions, testing laboratory, testing technician and time point of testing. Cut-offs and abbreviations: same as Table 1.

Journal: Clinical Neuropathology

Article Title: Clinical Neuropathology practice news 1-2014: Pyrosequencing meets clinical and analytical performance criteria for routine testing of MGMT promoter methylation status in glioblastoma

doi: 10.5414/NP300730

Figure Lengend Snippet: Summary of the results of MGMT promoter methylation testing in cases with methylated MGMT promoter according to the reference laboratory. There is a perfect correlation (100% concordance) of MGMT status in all samples irrespective of tissue fixation conditions, testing laboratory, testing technician and time point of testing. Cut-offs and abbreviations: same as Table 1.

Article Snippet: Case 8 , Sequenom , 2 , RCLPE , Epityper , 1 , 31.3 , methylated.

Techniques: Methylation

HOXA9 promoter methylation as marker for sensitivity and resistance in bladder cancer cell lines. ( A ) Expression profiling and hierarchical clustering of top sensitive and top resistant bladder cancer cell lines identifies candidate genes to explain sensitivity and resistance to chemotherapy. The LIMMA package (version 3.28.20) was used for analyzing differential expression of RNA sequencing (RNAseq) data between sensitive and resistant cell lines; ( B ) The HOXA9 promoter is methylated in resistant cell lines ( p < 0.001). Methylation quantification of the HOX9A promoter was carried out using the EpiTYPER assay.

Journal: Biomolecules

Article Title: An Epigenomic Approach to Improving Response to Neoadjuvant Cisplatin Chemotherapy in Bladder Cancer

doi: 10.3390/biom6030037

Figure Lengend Snippet: HOXA9 promoter methylation as marker for sensitivity and resistance in bladder cancer cell lines. ( A ) Expression profiling and hierarchical clustering of top sensitive and top resistant bladder cancer cell lines identifies candidate genes to explain sensitivity and resistance to chemotherapy. The LIMMA package (version 3.28.20) was used for analyzing differential expression of RNA sequencing (RNAseq) data between sensitive and resistant cell lines; ( B ) The HOXA9 promoter is methylated in resistant cell lines ( p < 0.001). Methylation quantification of the HOX9A promoter was carried out using the EpiTYPER assay.

Article Snippet: EpiTYPER (Sequenom) primers were designed to cover CpG islands associated with the respective HpaII amplifiable fragments.

Techniques: Methylation, Marker, Expressing, Quantitative Proteomics, RNA Sequencing, EpiTYPER Assay

HOXA9 promoter methylation is associated with chemoresistance of human muscle-invasive bladder cancer tissue. ( A ) CpG methylation at the HOXA9 promoter is increased in resistant compared to sensitive tumor samples. Methylation quantification of tumor samples was carried out using the EpiTYPER assay; ( B ) Based on methylation levels detected in the cisplatin sensitive cell lines, a cut-off methylation level of 12% was defined as predictive of cisplatin resistance. Resistant tumor samples ( n = 9) show methylation levels >12% ( p < 0.001).

Journal: Biomolecules

Article Title: An Epigenomic Approach to Improving Response to Neoadjuvant Cisplatin Chemotherapy in Bladder Cancer

doi: 10.3390/biom6030037

Figure Lengend Snippet: HOXA9 promoter methylation is associated with chemoresistance of human muscle-invasive bladder cancer tissue. ( A ) CpG methylation at the HOXA9 promoter is increased in resistant compared to sensitive tumor samples. Methylation quantification of tumor samples was carried out using the EpiTYPER assay; ( B ) Based on methylation levels detected in the cisplatin sensitive cell lines, a cut-off methylation level of 12% was defined as predictive of cisplatin resistance. Resistant tumor samples ( n = 9) show methylation levels >12% ( p < 0.001).

Article Snippet: EpiTYPER (Sequenom) primers were designed to cover CpG islands associated with the respective HpaII amplifiable fragments.

Techniques: Methylation, CpG Methylation Assay, EpiTYPER Assay